Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Clinical and Experimental Immunology
|
February 1, 1994
Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination
V Friman, M Quiding, C Czerkinsky, et al.
ACS Chemical Neuroscience
|
January 25, 2018
Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice
Katlyn A Fleming, Mark D Ericson, Katie T Freeman, et al.
Journal of Medicinal Chemistry
|
December 18, 2019
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists
Zoe M Koerperich, Mark D Ericson, Katie T Freeman, et al.
Journal of Advanced Nursing
|
May 1, 1995
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy
A Gardulf, H Björvell, V Andersen, et al.
ACS Chemical Neuroscience
|
August 22, 2020
Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice
Danielle N Adank, Mary M Lunzer, Mark D Ericson, et al.
Lancet (London, England)
|
February 11, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs
A Gardulf, V Andersen, J Björkander, et al.
ACS Pharmacology & Translational Science
|
April 18, 2024
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]
Mark D Ericson, Katie T Freeman, Courtney M Larson, et al.
Patient Education and Counseling
|
May 22, 2021
Virtual environments to study emotional responses to clinical communication: A scoping review
Justin J Sanders, Emma Caponigro, Jonathan D Ericson, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
March 10, 2022
Patient Preference for Telehealth Background Shapes Impressions of Physicians and Information Recall: A Randomized Experiment
Morgan D Stosic, Ja-Nae Duane, Brigitte N Durieux, et al.
Journal of Medicinal Chemistry
|
June 12, 2023
Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH<sub>2</sub>] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH<sub>2</sub>]
Mark D Ericson, Linh T Tran, Sarah S Mathre, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Clinical and Experimental Immunology
|
February 1, 1994
Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination
V Friman, M Quiding, C Czerkinsky, et al.
ACS Chemical Neuroscience
|
January 25, 2018
Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice
Katlyn A Fleming, Mark D Ericson, Katie T Freeman, et al.
Journal of Medicinal Chemistry
|
December 18, 2019
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists
Zoe M Koerperich, Mark D Ericson, Katie T Freeman, et al.
Journal of Advanced Nursing
|
May 1, 1995
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy
A Gardulf, H Björvell, V Andersen, et al.
ACS Chemical Neuroscience
|
August 22, 2020
Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice
Danielle N Adank, Mary M Lunzer, Mark D Ericson, et al.
Lancet (London, England)
|
February 11, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs
A Gardulf, V Andersen, J Björkander, et al.
ACS Pharmacology & Translational Science
|
April 18, 2024
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]
Mark D Ericson, Katie T Freeman, Courtney M Larson, et al.
Patient Education and Counseling
|
May 22, 2021
Virtual environments to study emotional responses to clinical communication: A scoping review
Justin J Sanders, Emma Caponigro, Jonathan D Ericson, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
March 10, 2022
Patient Preference for Telehealth Background Shapes Impressions of Physicians and Information Recall: A Randomized Experiment
Morgan D Stosic, Ja-Nae Duane, Brigitte N Durieux, et al.
Journal of Medicinal Chemistry
|
June 12, 2023
Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH<sub>2</sub>] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH<sub>2</sub>]
Mark D Ericson, Linh T Tran, Sarah S Mathre, et al.
Page
of 9